Evidence map›Paper›PMID 34091457›Full record

ArticleOncology research and treatment2021

MLH1 Exon 12 Gene Deletion Leading to Lynch Syndrome: A Case Report.

Shiyun Cui, Xiao Zhang, Ruihan Zou, Fan Ye, Yutong Wang, Jing Sun

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Oncology research and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shiyun CuiDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, cuishiyun@njmu.edu.cn.
Xiao ZhangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Ruihan ZouThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Fan YeThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Yutong WangThe First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Jing SunDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDeleterious heterozygous mutation of the MLH1 gene is an important cause of Lynch syndrome (LS), an autosomal dominant cancer caused by functional defects in the DNA mismatch repair (MMR) complex. CASE REPORT: The proband was a 35-year-old patient with confirmed colorectal cancer (CRC). Immunohistochemical (IHC) staining revealed the absence of MLH1 and PMS2 expression in the colorectal tissue specimens of the patient. Genetic counselling and tumor gene testing were performed using next-generation sequencing technology. The genetic tumor verification report showed the deletion of 4 bases in exon 12 of the tested MLH1 gene and a transcoding mutation. To our knowledge, this germline splice site mutation of MLH1 has not been reported before. The proband accepted several therapeutic regimens including PD-1 inhibitor and ultimately died of multiple organ failure.

conclusionNonsense mutations and frameshift mutations of MMR genes are the most common causes of LS. Common mutations include those in MSH2, MLH1, MSH6, and PMS2. We report a mutation of MLH1 that has never been reported before. We recommend that patients with a history of colon or rectal cancer receive universal MMR or MSI testing and checkpoint inhibitor therapy for the first-line treatment of deficient MMR CRC.

Indexed as

Colorectal Neoplasms, Hereditary NonpolyposisAdultDNA-Binding ProteinsDNA Mismatch RepairExonsGene DeletionGenetic Predisposition to DiseaseHumansMicrosatellite InstabilityMismatch Repair Endonuclease PMS2MutL Protein Homolog 1DNA-Binding ProteinsMismatch Repair Endonuclease PMS2MLH1 protein, humanMutL Protein Homolog 1Colorectal cancerGermline mutationLynch syndromeMismatch repairPD-1 inhibitors

Identifiers

PMID34091457
PMCPMC8495764
OpenAlexW3168732739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.